Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Corbus Pharmaceuticals Inc News

    35,54 $ 0,00% +0,00 $
    In : 33,194 € | 24.04.24 22:00:00 Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A3D54P
    ISIN: US21833P3010
    US-Symbol: CRBP
    Typ: Aktie

    Corbus Pharmaceuticals Inc News

    27.09.23 - PR Newswire
    Corbus Pharmaceuticals to Present Latest Pre-Clinical Data on its Anti-aVb8 Monoclonal Antibody (CRB-601) at the 2023 SITC Annual Meeting
    Corbus Pharmaceuticals to Present Latest Pre-​Clinical Data on its Anti-aVb8 Monoclonal Antibody (CRB-601) at the 2023 SITC Annual Meeting PR Newswire
    19.09.23 - PR Newswire
    Corbus Pharmaceuticals to Present Pre-Clinical Data Characterizing its CRB-701 Nectin-4 ADC at the at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
    Corbus Pharmaceuticals to Present Pre-​Clinical Data Characterizing its CRB-701 Nectin-4 ADC at the at AACR-​NCI-EORTC International Conference on Molecular Targets and ...
    08.08.23 - PR Newswire
    Corbus Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
    Corbus Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update PR Newswire
    31.07.23 - PR Newswire
    Corbus Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference
    Corbus Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference PR Newswire
    26.06.23 - PR Newswire
    Corbus Pharmaceuticals Set to Join Russell Microcap® Index
    Corbus Pharmaceuticals Set to Join Russell Microcap® Index PR Newswire
    31.05.23 - PR Newswire
    Corbus Pharmaceuticals to Participate in the 2023 Jefferies Healthcare Conference
    Corbus Pharmaceuticals to Participate in the 2023 Jefferies Healthcare Conference PR Newswire
    09.05.23 - PR Newswire
    Corbus Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
    Corbus Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update PR Newswire
    01.05.23 - PR Newswire
    Corbus Pharmaceuticals to Present Latest Pre-Clinical Data on CRB-601 avβ8 Blocking Antibody at the New York Academy of Sciences' Frontiers in Cancer Immunotherapy Meeting
    Corbus Pharmaceuticals to Present Latest Pre-​Clinical Data on CRB-601 avβ8 Blocking Antibody at the New York Academy of Sciences' Frontiers in Cancer Immunotherapy Meeting ...
    18.04.23 - PR Newswire
    Corbus Pharmaceuticals Hosting Virtual 'Meet the Expert' Series: Blocking TGFβ with CRB-601--a New Play for an Old Target
    Corbus Pharmaceuticals Hosting Virtual 'Meet the Expert' Series: Blocking TGFβ with CRB-601--a New Play for an Old Target PR Newswire
    17.04.23 - PR Newswire
    Corbus Pharmaceuticals Presents Latest Pre-Clinical Data on CRB-601 at the 2023 American Association for Cancer Research Annual Meeting
    Corbus Pharmaceuticals Presents Latest Pre-​Clinical Data on CRB-601 at the 2023 American Association for Cancer Research Annual Meeting PR Newswire
    17.03.23 - PR Newswire
    Thinking about buying stock in Corbus Pharmaceuticals, Marathon Digital, Riot Platforms, CleanSpark, or BigBear.ai?
    Thinking about buying stock in Corbus Pharmaceuticals, Marathon Digital, Riot Platforms, CleanSpark, or BigBear.ai? PR Newswire
    14.03.23 - PR Newswire
    Corbus Pharmaceuticals Data on CRB-601 avβ8 Blocking Antibody Accepted for Presentation at the America Association for Cancer Research Annual Meeting
    Corbus Pharmaceuticals Data on CRB-601 avβ8 Blocking Antibody Accepted for Presentation at the America Association for Cancer Research Annual Meeting PR Newswire
    06.03.23 - PR Newswire
    Corbus Pharmaceuticals Expands Board of Directors with Appointment of Yong Ben, M.D., MBA
    Corbus Pharmaceuticals Expands Board of Directors with Appointment of Yong Ben, M.D., MBA PR Newswire
    02.03.23 - PR Newswire
    Corbus Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference
    Corbus Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference PR Newswire
    13.02.23 - PR Newswire
    Corbus Pharmaceuticals expands oncology pipeline with the addition of a clinical stage Nectin-4 targeting Antibody Drug Conjugate (ADC)
    Corbus Pharmaceuticals expands oncology pipeline with the addition of a clinical stage Nectin-4 targeting Antibody Drug Conjugate (ADC) PR Newswire
    30.11.22 - PR Newswire
    Thinking about buying stock in Nio, Kalera, Salesforce, Corbus Pharmaceuticals, or Full Truck Alliance?
    Thinking about buying stock in Nio, Kalera, Salesforce, Corbus Pharmaceuticals, or Full Truck Alliance? PR Newswire
    10.11.22 - PR Newswire
    Corbus Presents Latest Preclinical Data for CRB-601 at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
    Corbus Presents Latest Preclinical Data for CRB-601 at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting PR Newswire
    08.11.22 - PR Newswire
    Corbus Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
    Corbus Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update PR Newswire
    14.10.22 - PR Newswire
    Corbus Pharmaceuticals to Present Pre-Clinical Data for CRB-601 at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
    Corbus Pharmaceuticals to Present Pre-​Clinical Data for CRB-601 at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting PR Newswire
    26.09.22 - PR Newswire
    Thinking about buying stock in Aditxt, RedHill Biopharma, Corbus Pharmaceuticals, Li Auto, or Kiora Pharmaceuticals?
    Thinking about buying stock in Aditxt, RedHill Biopharma, Corbus Pharmaceuticals, Li Auto, or Kiora Pharmaceuticals? PR Newswire

    Newssuche

    Videos

    newspaper
    24.04.24
    Technical Trading: AUD/USD mit Mega Chance
    AUD/USD Long Typ: Turbo Open End WKN: UM0EHU Hebel: 6,42 Laufzeit: OpenEnd Einstieg: Market ... Mehr »